Stay updated on Nivolumab in ER+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in ER+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    New resources and documents have been added to the trial page, including a PDF of the Study Protocol and Statistical Analysis Plan provided by Bristol-Myers Squibb, and sponsor sections for clinical trial recruitment and information. The page also includes a Publications section and expanded keywords, improving access to official materials and related literature.
    Difference
    100%
    Check dated 2026-07-04T08:20:48.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision: v3.6.2 is now shown on the page. Several sponsor- and document-related footer items were removed, which changes how study documents and sponsor context are accessed while leaving the core trial details unchanged.
    Difference
    16%
    Check dated 2026-06-27T04:13:53.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page adds a recruitment status note and new guidance sections to help users join or understand the study, and updates the revision tag to v3.6.0 while adjusting the Intervention/Treatment heading.
    Difference
    0.1%
    Check dated 2026-06-12T23:36:09.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now displays the latest revision label Revision: v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the page versioning rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-06-05T19:18:32.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    A new revision label v3.5.4 has been added, replacing the previous v3.5.3. This indicates an update to the page's revision history rather than any changes to the study content.
    Difference
    0.0%
    Check dated 2026-05-15T05:47:50.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    This change adjusts how the Chilean Valparaíso location is presented (e.g., region wording) while keeping the same city/address line for that site. It also reflects an automated site version/revision update without altering the study’s scientific or participant-relevant details.
    Difference
    0.2%
    Check dated 2026-04-23T21:56:14.000Z thumbnail image

Stay in the know with updates to Nivolumab in ER+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.